In the News
Abe Hamadeh Calls for Review of Thyroid Drug Actions Following FDA ControversyClick here to read this news story
Washington, DC,
November 6, 2025
Congressman Abe Hamadeh is asking the Food and Drug Administration to halt its recent actions against certain thyroid medications following the resignation of a top FDA official amid serious allegations. |
